Center for Scientific Review; Notice of Closed Meetings
Published Date: 11/26/2025
Notice
Summary
The Center for Scientific Review is holding a closed virtual meeting on January 16, 2026, to review important grant applications related to neuroscience and vision research. These meetings are private to protect sensitive information and personal privacy. Scientists applying for grants and the research community are affected, but there’s no direct cost or public access involved.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Grant Review Closed to Public
The NIH Center for Scientific Review will hold a closed virtual meeting on January 16, 2026 from 9:30 a.m. to 6:00 p.m. to review fellowship grant applications. The meeting is closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, patentable material, and personal information.
Neuroscience and Vision Fellowships Reviewed
The Special Emphasis Panel for Fellowships in Biophysical, Physiological, Pharmacological and Bioengineering Neuroscience and Vision will review and evaluate grant applications on January 16, 2026 in a virtual meeting. If you applied to these fellowships, your application will be considered during that meeting.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11390 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding to advance science. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-11367 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for exciting science projects. If you’re involved in cell biology, heart disease, mental health, or cancer research, these reviews could impact your funding timeline and opportunities.
2026-11357 — National Library of Medicine; Notice of Partially Closed Meeting
The National Library of Medicine’s Board of Regents will hold a virtual meeting on July 16, 2026, with some parts open to the public and others closed to protect private info and trade secrets. This meeting affects researchers and grant applicants, as grant reviews will happen behind closed doors. Anyone can watch the open sessions online and send comments up to 15 days before the meeting—no registration needed!
2026-11018 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late June and early July 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which scientific projects get funding. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-10814 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and evaluate important grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists and researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-10813 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health just announced a cool new antibody called 18H2 that helps scientists spot a key protein in immune cells that keep us healthy. This invention is ready for companies to license and turn into real products, speeding up research and treatments for autoimmune diseases. If you’re interested, now’s the time to reach out and get the details—money and timing depend on your licensing deal!
Previous / Next Documents
Previous: 2025-21261 — Foreign-Trade Zone (FTZ) 89; Authorization of Limited Production Activity; GPI Beauty, Inc.; (Plastic Tube Sleeves); Las Vegas, Nevada
GPI Beauty, Inc. in Las Vegas got the green light to make plastic tube sleeves inside Foreign-Trade Zone 89, but only for three years. They must keep buying at least 85% of their materials from U.S. sources each year to keep this special status. This move helps the company grow while supporting American suppliers, with the government keeping a close eye on progress.
Next: 2025-21263 — Foreign-Trade Zone (FTZ) 43; Authorization of Limited Production Activity; Pfizer, Inc.; (Pharmaceutical Intermediate Product); Kalamazoo, Michigan
Pfizer in Kalamazoo got the green light to start limited production of a pharmaceutical intermediate product in their Foreign-Trade Zone. This special permission lasts for one year and helps Pfizer speed up their work while following trade rules. It’s a win for local jobs and innovation, with close monitoring to keep everything on track.